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Abstract
Background: The urokinase receptor (uPAR/CD87) is highly expressed in malignant tumours. uPAR, as a GPI anchored
protein, is preferentially located at the cell surface, where it interacts with its ligands urokinase (uPA) and the extracellular
matrix protein vitronectin, thus promoting plasmin generation, cell-matrix interactions and intracellular signalling events.
Interaction with a complex formed by uPA and its inhibitor PAI-1 induces cell surface down regulation and recycling of the
receptor via the clathrin-coated pathway, a process dependent on the association to LRP-1.
Methodology/Principal Findings: In this study, we have found that along with the ligand-induced down-regulation, uPAR
also internalizes and recycles constitutively through a second pathway that is independent of LRP-1 and clathrin but shares
some properties with macropinocytosis. The ligand-independent route is amiloride-sensitive, does not require uPAR
partitioning into lipid rafts, is independent of the activity of small GTPases RhoA, Rac1 and Cdc42, and does not require PI3K
activity. Constitutively endocytosed uPAR is found in EEA1 positive early/recycling endosomes but does not reach
lysosomes in the absence of ligands. Electron microscopy analysis reveals the presence of uPAR in ruffling domains at the
cell surface, in macropinosome-like vesicles and in endosomal compartments.
Conclusions/Significance: These results indicate that, in addition to the ligand-induced endocytosis of uPAR, efficient
surface expression and membrane trafficking might also be driven by an uncommon macropinocytic mechanism coupled
with rapid recycling to the cell surface.
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Introduction
By localizing the proteolyticactivity at theplasmamembrane and
modulatingcelladhesion,migrationand proliferation,theurokinase
receptor (uPAR/CD87) plays an important role in processes such as
wound healing, stem cell mobilization, inflammation, HIV-1
replication, tumour progression and metastasis [1]. uPAR is a
glycosylphosphatidylinositol (GPI) anchored protein that binds the
urokinase-type plasminogen activator (uPA) at the cell surface thus
promoting the conversion of plasminogen into plasmin. Plasmin
generation triggers the activation of proteolytic cascades that lead to
the degradation of the extracellular matrix (ECM). Lacking
transmembrane and cytosolic domains, uPAR is unable to
transduce signals. It is therefore generally believed that uPAR
associates and activates transmembrane receptors on the cell
surface. uPAR has been reported to associate to various proteins
like integrins, receptor tyrosine kinases (e.g. EGFR) and a G-protein
coupled receptor (e.g. FPRL1), thus affecting cell adhesion,
migration and proliferation [1]. However, the direct interaction of
uPAR with vitronectin, a protein present in the ECM, has been
reported to suffice for the induction of at least part of the uPAR-
induced cell signalling, resulting in dramatic changes in cell
morphology and increased cell motility [2]. As a GPI-anchored
protein, uPAR should be found in lipid microdomains and/or
clustered within caveolae, a specialized form of lipid rafts [3].
However, careful biochemical measurements have shown that only
a fraction of uPAR segregates with detergent resistant membranes
(DRM), the rest partitioning with the detergent soluble (DS)
membranes [4–5]. Lipid rafts partitioning of uPAR is associated
with uPAR dimerization and binding to vitronectin, while
plasminogen activation by uPAR-bound uPA is independent of its
lipid environment [4]. Interestingly, binding of uPA not only
promotes plasminogen activation but also regulates the partitioning
of uPAR into lipid rafts independently of its catalytic activity, and
such localization is important for uPAR-dependent signalling [5–6].
Although an appropriate lipid environment seems to be important
for some signalling function of uPAR, their role during uPAR
endocytosis remains unknown.
Although tethered to the plasma membrane by a GPI anchor,
uPAR is efficiently removed from the cell surface via clathrin coated
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association with LDL receptor-related protein-1 (LRP-1) or other
members of the LDL receptor family. In the proposed model, the
specific uPA inhibitor plasminogen activator inhibitor type-1 (PAI-1)
binds covalently to uPAR-bound uPA thus inhibiting its enzymatic
activity. The ternary uPAR:uPA:PAI-1 complex rapidly associates to
LRP-1andissequesteredinclathrin-coatedpits.Theligandsarethen
targeted to the lysosomes for degradation, while the receptors recycle
back to the cell surface [7–9]. The partitioning of uPAR within
specific domains of the plasma membrane that undergo clathrin-
independent endocytosis and macropinocytosis (lipid rafts and
ruffles/lamellipodia) suggests that other endocytic mechanisms may
regulate uPAR trafficking as well. In mammalian cells, even if
clathrin-dependent internalization is the best-characterized pathway
ofendocytosis,severalotherclathrin-independentpathwayscoexistin
the same cell [10]. Cargo and machinery proteins regulating these
alternative pathways are still poorly characterized; however, it is
largely accepted that most of them require cholesterol and that the
primary transport carriers eventually merge at the level of the early
endosome overlapping with other pathways.
We have undertaken a study of uPAR endocytosis utilizing two
cell lines. HEK293-uPAR, an uPAR overexpressing highly-motile
cellline,doesnotproduceuPAorPAI-1and hencecannot carryout
uPA:PAI-1-triggered, clathrin-dependent endocytosis. The other
motile cell line (HT1080, a human fibrosarcoma expressing high
levels of uPAR) on the other hand also expresses high levels of
uPAR, uPA and PAI-1 and therefore undergoes clathrin-dependent
endocytosis of uPAR. Importantly, both cell lines express LRP-1.
In this report, we have established the existence of a second
constitutive endocytic route for uPAR internalization. In fact, in
addition to the uPA:PAI-1- and LRP-1-mediated route, both cell
lines possess an uncommon uPA:PAI-1-independent, lipid rafts-
independent but amiloride-sensitive, macropinocytic-like process
that is associated with rapid recycling of uPAR to the cell surface.
This endocytic mechanism might support the sustained expression
of uPAR at its functional sites as well as ensuring the preservation
of a constant membrane area.
Results
uPAR is found in early and late/lysosomal compartments
in the presence of endogenous ligands
Formation of the quaternary uPAR:uPA:PAI-1:LRP-1 complex
on the cell surface is known to induce clathrin-mediated internali-
zation of the whole uPAR complex, resulting in degradation of the
ligands (uPA and PAI-1) and recycling of the receptors (uPAR and
LRP-1) [7-8-9]. HT1080 cells express high levels of uPAR, LRP-1,
uPA and PAI-1. Therefore, we have assessed the ability of uPAR to
internalize in the presence of endogenous ligands by confocal laser
microscopy. As shown in Fig. 1,HT 1 0 8 0ce ll sc o n t a i nu PA Ri ne a rl y
endosomal (EEA1 positive) as well as late endosomes/lysosomes
(LAMP-1 positive). This observation was confirmed by immuno-
electron microscopy using a monoclonal antibody to human uPAR
(R3) and 10 nm protein A-gold for detection, which identified uPAR
in both early and late endosomal structures loaded with 5 nm BSA-
gold for 2 hours at 37uCa se n d o c y t i ct r a c e r( Fig. 1, right). These
results indicate that the endogenous uPA:PAI-1 complexes readily
internalize and specifically promote partial lysosomal targeting of
uPAR in migratory HT1080 cells.
uPAR is endocytosed in the absence of ligands by a
constitutive, uPA:PAI-1 independent pathway
In order to study whether uPAR can be internalized
independently of its uPA:PAI-1 binding, we took advantage of
the human embryonic kidney 293 cell line (HEK293) as these cells
do not express endogenous uPAR, uPA nor PAI-1 [4, and our
unpublished gene expression profiling, not shown]. Stable uPAR
expression in these cells leads to the formation of multiple
advancing protrusions that resemble the leading-edge of migratory
cells [2]. We therefore analysed the subcellular distribution of
uPAR by confocal laser microscopy. Confocal images of HEK293-
uPAR cells labelled with anti-uPAR antibodies showed that uPAR
was largely located at the cell surface, predominantly in large
lamellipodia-like structures and in intracellular vesicles of different
size (Fig. 2 left). Interestingly, a fraction of uPAR was found in
EEA1-positive early endosomal compartments but not in LAMP-
1-positive lysosomal compartments (Fig. 2 right). These results
suggest that in HEK293-uPAR cells the urokinase receptor may be
endocytosed also in the absence of uPA and PAI-1, indicating the
presence of a constitutive uPAR endocytic pathway. The presence
of uPAR in EEA-1-positive membranes in both HEK293-uPAR
and HT1080 cells suggests that the two pathways might overlap at
the level of the early endosomal system, even though probably
distinct mechanisms probably regulates the initial entry. In fact,
several evidences show that many clathrin-independent endocytic
pathways eventually merge at the level of early (EEA-1 positive)
endosome [10–12].
Figure 1. uPAR is present in early endosomes and late endosomes/lysosomes in the presence of endogenous ligands (HT1080
cells). Immunofluorescence of HT1080 cells (left panel) co-stained with anti-uPAR antibody (green) and monoclonal antibody anti-EEA1 (red, top)
and monoclonal antibody anti-LAMP1 (red, bottom), respectively, and visualized with confocal laser microscopy. Overlays (merge) show the co-
localization of uPAR with EEA1 and LAMP-1 positive membranes (yellow). Scale bars 10 mm. On the right side is shown a representative electron
micrograph of uPAR (protein A gold 10 nm) present in early endocytic (full arrow) and lysosomal (arrowhead) compartments previously loaded with
BSA 5 nm gold for 2 hours as fluid phase tracer. Scale bar 200 nm.
doi:10.1371/journal.pone.0003730.g001
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of uPAR in endocytic compartments, we also performed
biochemical studies. First, we demonstrated the existence of the
constitutive uPAR internalization pathway. HT1080 and
HEK293-uPAR cells were acid washed (in order to remove any
pre-bound ligands), and then incubated at 4uC with a cross-linking
biotin derivative (that does not cross the plasma membrane and
can be removed from the cell surface by reduction with reduced
glutathione, GSH). The cells were then incubated at 4uC with or
without uPA:PAI-1 complexes, and then shifted to 37uC to allow
internalization. At this point cells were treated with reduced
glutathione to remove the cell surface-associated biotin and lysed.
The lysates were immunoprecipitated with anti-uPAR antibodies,
blotted and membranes treated with HRP-streptavidin. Fig. 3A
shows as expected the presence of biotinylated (i.e. endocytosed)
uPAR in HT1080 cells both in the absence and presence of
exogenous uPA:PAI-1; however, the presence of uPA:PAI-1
increases the level of biotinylated intracellular uPAR. When the
same experiment was performed in HEK293-uPAR cells in the
absence of exogenous uPA:PAI-1, a fraction of uPAR was also
internalized at 37uC, confirming the existence of a constitutive,
uPA:PAI-1-independent pathway (Fig. 3B). We then performed a
time-course analysis of constitutive uPAR endocytosis, and
observed that the process was time-dependent (Fig. 3C). In this
experiment, the presence of the second uPAR band is in
agreement with the cleavage of uPAR between domains DI and
DII [4].
To more precisely quantify the fraction of internalized uPAR,
we developed a flow cytometry assay that evaluates uPAR
endocytosis in HEK293-uPAR cells (see Materials and Methods).
Briefly, adherent cells were first incubated with anti-uPAR
polyclonal antibodies for 30 min on ice, washed to remove the
unbound antibody and then transferred to 37uC for 15 min. After
this internalization-period, the antibodies remaining at the cell
surface were removed by acid washing at 0uC. Flow-cytometry
analysis showed that a fraction of cell surface uPAR (17.5%) was
internalized during the 37uC incubation (Fig. 3D), in agreement
with the biochemical data.
Finally, we tested whether constitutively endocytosed uPAR
could recycle back to the cell surface. For this purpose,
biotinylated HEK293-uPAR cells were incubated at 37uC for
20 minutes, treated with GSH to remove cell-surface biotin,
reincubated at 37uC for 10 or 20 minutes, and the amount of cell-
surface (recycled) uPAR evaluated after a second GSH treatment
by immunoprecipitation with anti-uPAR antibodies and immu-
noblotting with HRP. The data (Fig. 3E) show that the initial
GSH treatment removes biotin from the extracellular uPAR (lane
1) and that incubation at 37uC for 20 minutes leads to a
substantial GSH-resistance of biotinylated uPAR (i.e. uPAR is
internalized) (lane 3). After this step, a second GSH-treatment
performed after a econd 37uC incubation, allowed to determine
the amount of GSH-sensitive uPAR (i.e. on the cell surface). This
increased with the time (lanes 5 and 7), showing that previously
endocytosed uPAR was recycled back to the cell surface. The
immunoblotting of Fig. 3E also show that a substantial amount of
uPAR is lost (degraded/shedded) during this second incubation.
Figure 3F quantifies both recycling and degradation/shedding.
The constitutive pathway is clathrin and LRP-1
independent
We next addressed the mechanism regulating the initial entry of
uPAR in the absence of uPA:PAI-1 complexes and tested the
involvement of the clathrin-dependent pathway. To address this
question, we performed confocal double immunofluorescence in
HEK293-uPAR cells using antibodies to clathrin and LRP-1 as
specific markers for the uPA:PAI-1-dependent, clathrin- and LRP-
1-mediated endocytic pathway. As seen in Fig. 4A, in these cells
uPAR did not co-localize with clathrin or LRP-1at the level of
lamellipodia-like membrane domains nor at the cell-cell junctions.
In fact, clathrin and LRP-1 were completely excluded from these
specialized regions and mainly located in the cell body. The spatial
segregation of these endocytic markers and the overall absence of
co-localization are suggestive of a potential clathrin- and LRP-1-
independent mechanism responsible for constitutive uPAR
endocytosis.
Hypertonic treatment of cells is a traditional method used to
inhibit clathrin-coated pit formation and clathrin-mediated
endocytosis [13]. Fig. 4B shows that the intracellular distribution
of uPAR in early endocytic (EEA1 positive) components was not
affected by incubation of the cells in hypertonic medium (0.45 M
Sucrose, 45 minutes at 37uC). This treatment, on the other hand,
totally abolished clathrin-mediated endocytosis of Transferrin
(Figure 4B) and uPA:PAI-1 internalization (not shown), as
expected. Overall, these results reveal the existence of a
constitutive uPAR internalization route and suggest that it must
be different from the ligand-induced clathrin-mediated pathway.
Figure 2. uPAR is found in endocytic compartments in the absence of ligands in HEK293-uPAR cells. Immunofluorescence of HEK293-
uPAR cells labeled with a polyclonal anti-uPAR antibody and imaged by confocal microscopy. Image 2 (left), shows the predominant location of uPAR
in lamellipodia-like protrusions and in intracellular compartments, including large vesicles (arrowheads). Image 2 (right), shows a different z-axis of
the same cell where large putative macropinosomes are evident (arrowheads, inset 36magnification). Scale bar 10 mm. Image 2B shows HEK293-
uPAR co-stained with the early endocytic marker EEA-1 and the late endocytic/lysosomal marker LAMP-1. In these cells, internal uPAR (green) is not
present in the lysosomal compartment as shown by the lack of overlap with LAMP-1 (red). On the other hand, intracellular uPAR (green) completely
overlapped with EEA-1 positive puncta (arrowheads). Note the large lamellipodia-like protrusions induced by uPAR expression. Scale bar 10 mm.
Insets are magnifications of the relevant areas.
doi:10.1371/journal.pone.0003730.g002
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independent uPAR endocytosis, we performed experiments in
the presence of the specific LRP-1 antagonist RAP (Receptor-
Associated Protein), which inhibits uPA:PAI-1 endocytosis [7,8].
Indeed, 200 nM RAP did not prevent constitutive internalization
of uPAR in HEK293-uPAR cells as demonstrated by cell surface
biotinylation and immunoblotting of the cell extracts, as well as by
immunofluorescence analysis. As shown in Fig. 4C after
incubation of cells for 15 minutes at 37uC and removal of the
external biotin with glutathione, uPAR was allowed to internalize
in the presence of RAP. No inhibition was observed in the level of
internalization, compared to controls (lane 1 versus lane 2),
indicating that constitutive endocytosis of uPAR is LRP-1-
independent. On the contrary, in the presence of uPA:PAI-1,
uPAR is internalized at a higher rate, which is inhibited by RAP
(compare lanes 3 and 4). Immunofluorescence analysis of
HEK293-uPAR cells pre-incubated with a fluorescent monoclonal
anti-uPAR antibody on ice and then washed and transferred to
37uC for 10 min also demonstrated internalization of the
fluorescent anti-uPAR antibody even in the presence of RAP
(Fig. 4D). The specificity of RAP to LRP-1 and uPAR
internalization was also demonstrated by immunofluorescence
since it specifically inhibited uPA:PAI-1-Cy3 but not Transferrin
endocytosis (Fig. 4D). We conclude that the constitutive
internalization of unbound uPAR is independent of LRP-1.
To confirm the clathrin-independence, we blocked clathrin-
mediated internalization with a dominant negative, GFP-tagged,
mutant of Eps15, EpsD95/295, known to impair the interaction
withclathrin adaptor proteinssuchasAP-2,andevaluatedtheeffect
on constitutive uPAR endocytosis. We tested by confocal micros-
copy the ability of anti-uPAR R3 antibody to be internalized in
HEK293-uPAR cells transfected with the Eps15 mutant. As shown
in Fig. 4E, while the internalization of fluorescent transferrin-Cy3
was inhibited in GFP-positive cells, anti-uPAR antibodies were
internalized in the presence of the Eps15 mutant as well as of
200 nMRAP.Theseresultssupport the idea thatconstitutiveuPAR
endocytosis is not mediated by LRP-1 or clathrin.
Lipid rafts are not involved in uPAR endocytosis.
We then turned our attention to the role of uPAR partitioning
into lipid rafts in constitutive endocytosis. Previous work showed
that uPAR resides in lipid rafts, and that this localization is
important for certain functions of the receptor, such as vitronectin
binding and signal transduction [4]. We therefore investigated the
role of lipid rafts in uPA:PAI-1-dependent and -independent uPAR
endocytosis. We first tested whether uPAR and other relevant
proteins were associated with the detergent-resistant membrane
(DRM) obtained after solubilization of HEK293-uPAR cells in
Triton X-100 at 4uC. Flotation in sucrose density gradients [14]
showed (Fig. 5A) that only a fraction of uPAR partitioned to
DRMs, whereas the largest fraction was found in the detergent-
soluble (DS) part of the gradients. These results indicate that a
minor fraction of uPAR is enriched in lipid rafts. While caveolin-1
displays a similar distribution, the Transferrin receptor is present
only in the DS fractions, as expected. Interestingly, both LRP-1 and
clathrin partitioned exclusively to the DS fractions, like b1 integrin
and the endocytic marker EEA1 (Fig. 5B). In cells depleted of
cholesterol with beta-methyl-cyclodextrin (mCD, 10 mM, 30 min.
37uC), uPAR was found only in DS fractions (Fig. 5B).
Since uPAR partitions to both detergent-resistant and deter-
gent-soluble fractions, we tested whether partitioning in lipid rafts
was necessary for ligand-dependent and -independent uPAR
endocytosis. We performed an internalization assay combining cell
surface biotinylation with sucrose density gradients (see Materials
and Methods). As shown in Fig. 5C, biotinylated cell surface
uPAR was partially located in the lipid raft fraction, but after
15 min. at 37uC, the (internalized) biotinylated receptor parti-
tioned exclusively to the DS fractions, both in the absence or
presence of uPA:PAI-1. Beta-methyl-cyclodextrin (mCD) did not
inhibit the uPA:PAI-1-dependent (not shown) nor constitutive
uPAR endocytosis (Fig. 5C), suggesting that uPAR endocytosis
does not require lipid rafts. Altogether, these results indicate that
lipid rafts are not involved in either the uPA:PAI-1-dependent or
-independent endocytic pathway.
Figure 3. uPAR is constitutively internalized in the absence of
ligands. In all cases, the images presented are representative of 3–5
independent experiments. Panel A shows a biotinylation assay
performed in HT1080 cells. Cells were acid-washed in order to remove
pre-bound ligands, surface biotinylated and then internalization was
allowed for 15 minutes at 37uC. Western Blots analysis of cell extracts
revealed that uPAR is being internalized in the absence of uPA:PAI-1 in
HT1080 (lane 1: background, lane 2: internalized uPAR in the absence of
uPA:PAI-1, lane 3: internalized uPAR in the presence of uPA:PAI-1, lane
4: total biotinylated uPAR). Panel B shows the same experiment in
HEK293-uPAR cells (Lane 1: background, Lane 2: internalized uPAR in
the absence of uPA:PAI-1, Lane 3: total biotinylated uPAR). Panel C
shows the biotinylation assay performed in HEK293-uPAR cells, where
internalization was allowed for different times, as indicated (total: total
biotinylated uPAR). Panel D shows uPAR endocytosis measured by cell
cytometry assay in HEK293-uPAR cells. HEK293-uPAR cells were first
incubated with anti uPAR polyclonal antibodies bound to Neutravidin-
PE for 30 min at 0uC, and then the temperature was raised for 15 min to
37uC. Samples were also incubated at 0uC to account for unspecific
binding. After this period, the remaining antibodies at the cell surface
were removed by acid washing at 0uC. By cell cytometry we obtained
fluorescent intensity values that allow us to calculate the amount of
internalized receptor as % of total cell surface uPAR (see materials and
methods). White bar: amount of receptor internalized at 4uC. Grey bar:
amount of receptor internalized at 37uC. Black bar: actual amount of
receptor internalized at 37uC after 15 min, corresponding to 17.5% of
cell surface uPAR. Panel E shows the biotinylation assay performed to
follow uPAR recycling (see description of the experiment in the text).
Lane 1: background. Lane 2: total biotinylated uPAR. Lane 3:
internalized uPAR at 37uC (first step). Lane 4 and 6: internalized uPAR
(second step) for 10 and 20 minutes 37uC, respectively, without GSH
treatment. Lane 5 and 7: internalized uPAR (second step) for 10 and
20 minutes at 37uC, respectively, with GSH treatment. Panel F shows
the time-course of uPAR recycling to the cell surface and of its
degradation or shedding. The data are expressed in percent of
receptors internalized after 20 minutes that is recycled to the plasma
membrane (continuous line) or that is lost dring the second incubation
(dotted line).
doi:10.1371/journal.pone.0003730.g003
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pathway
GPI-anchored proteins are known to be excluded from clathrin
coated pits [15], to associate with caveolae upon antibody cross-
linking [16], to be enriched in uncoated tubular carriers termed
CLICs/GEEC (early endosomal GPI-enriched comparment) [17]
and to be sorted into macropinosomes under certain conditions
[18–19]. The ultrastructure of the compartment by which uPAR is
Figure 4. Constitutive endocytosis of uPAR is LRP-1-independent. Panel A: HEK293-uPAR were stained with R3 uPAR (green) and clathrin
heavy chain antibodies (red) or with uPAR (red) and LRP-1 antibodies (green). Representative confocal images are displayed. Note that uPAR-rich
lamellipodia-like protrusions of HEK293-uPAR cells were largely devoid of clathrin and LRP-1, indicating spatial segregation between uPAR and these
endocytic markers. Scale bars 10 mm. Panel B shows acid washed HT1080 cells cultured with Hypertonic Medium to block clathrin-coated pits
assembly (0.45 M Sucrose, 45 minutes at 37uC) [13]. Immunofluorescence of uPAR and EEA1 shows co-localization in untreated as well as Sucrose
treated cells. The treatment did not change uPAR distribution, although a minimal effect on the organization of the early endosomal compartment
was observed. As a control, Transferrin-cy3 was bound to the surface, washed and shifted for 30 minutes at 37uC in untreated and treated cells. As
expected, Sucrose treatment significantly perturbed Transferrin entry into the endosomal system. Scale bars 10 mm. Panel C (left) shows a
biotinylation assay of uPAR internalization. HEK293-uPAR cells were incubated with 200 nM RAP (Receptor Associated Protein) for 1 hour at 0uCi n
order to inhibit LRP-1association to uPAR, biotinylated, shifted at 37uC for 15 minutes and GSH-treated. (Lane 1: untreated cells, Lane 2: cells treated
with 200 nM RAP, Lane 3: cells treated with 50 nM uPA:PAI-1), Lane 4: cells treated with both 50 nM uPA:PAI-1 and 200 nM RAP). Western Blot
analysis indicated that constitutively internalized uPAR is not sensitive to RAP treatment. The right section shows the quantitation of the data
obtained by densitometric analysis of the blots. Endocytosis of untreated cells is given the arbitrary value of 1. Panel D shows the uptake of uPAR,
uPA-PAI1-cy3 and Transferrin-cy3 in untreated or RAP-treated cells by confocal imaging. HEK293-uPAR cells were incubated with a monoclonal Ab
anti-uPAR (R3), uPA-PAI1-cy3 and Transferrin-cy3 for 15 minutes on ice, and then extensively washed before being shifted at 37uC for 15 minutes.
Cells were fixed in 3% paraformaldehyde, permeabilized with 0.1% saponin and labelled with anti-mouse cy3 antibody for uPAR detection. Images
show that anti-uPAR antibody internalization is not perturbed by RAP treatment (middle panel). On the contrary, uPA-PAI-cy3 endocytosis was
strongly inhibited by RAP (right panel). As expected, Transferrin endocytosis was not perturbed by RAP treatment (left panel). Scale bars 10 mm.
Panel E shows the effect of the GFP-tagged dominant-negative mutant of eps15 (Eps15 D95/295, green) on uPAR ligand-independent uptake by
confocal imaging. HEK293-uPAR cells were incubated with anti-uPAR monoclonal antibody and Transferrin-cy3 on ice, washed and then shifted for
15 minutes at 37uC. As expected, cells transfected with the eps15 mutant completely abolished Transferrin uptake (upper panel). Internalization of
anti-uPAR antibodies occurred in both cells transfected with the eps15 mutant (middle panel) as well as in cells treated with RAP (lower panel).
Images are representative of three different experiments. Scale bars 10 mm.
doi:10.1371/journal.pone.0003730.g004
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the uptake of the monoclonal anti-uPAR Aantibody (R3) in
HEK293-uPAR cells and used 10 nm protein A-gold for
detection. uPAR and Protein A gold complexes were readily
internalized in HEK293-uPAR cells. As shown in Fig. 6 (t=0),
prior to internalization uPAR was evident in ruffling regions (R) of
the plasma membrane as well as in distinct non-ruffling domains.
Notably, uPAR was largely excluded from clathrin-coated pits
(CP) (t=0, inset). Upon 5 minutes at 37uC, uPAR was observed
in a variety of structures such as closing ruffles and was clustered
within distinct large structures (up to 0.4 mm in diameter)
originating from the plasma membrane, with the morphology
and size of macropinosomes (MP) (t=5, insets). Consistently
with the light microscopy data, uPAR was observed both in large
putative macropinosomes (MP) and early endosomes (EE) after
20 minutes at 37uC( t=20). In (t=20 RAP) HEK293-uPAR cells
were treated with 200 nM RAP for 1 hour at 37uC prior to the
internalization assay in the presence of anti-uPAR R3 antibody
and Protein A gold 10 nm. As expected from the RAP-
independence of the process (Fig. 4), upon 20 minutes of
internalization uPAR was found in putative macropinosomes as
well as in endosomal structures but not in clathrin coated pits (CP,
inset). These results suggest that a macropinocytic mechanism
represents the constitutive pathway responsible for a significant
fraction of constitutive uPAR endocytosis.
Constitutive uPAR endocytosis occurs via an amiloride-
sensitive endocytic route
The aforementioned results and the localization of uPAR at
membrane ruffles and lamellipodia strongly suggest the possible
involvement of macropinocytosis [20–21]. Sensitivity to inhibitors
of Na/H exchangers (e.g. amiloride) is a characteristic of this
process [22–23]. Consequently we examined the constitutive
internalization of uPAR in the presence or absence of amiloride.
Using cell surface biotinylation, we observed that uPAR
endocytosis was markedly reduced (up to 50%) in a dose-
dependent manner by amiloride (Fig. 7, A–B). Next, we
compared by flow cytometry the effect of amiloride on uPAR,
LRP-1, Transferrin, CD59 and dextran endocytosis in HEK293-
uPAR cells. Unlike LRP-1 and Transferrin receptors that
internalize through clathrin-coated pits, CD59 is a GPI-anchored
receptor, like uPAR. Dextran, on the other hand, is a fluid phase
marker internalized by macropinocytosis. As shown in Fig. 7C,
amiloride markedly reduced uPAR and dextran, but not
Transferrin endocytosis. Likewise, amiloride significantly inhibited
the GPI-anchored CD59 but not LRP-1 endocytosis (Fig. 7D).
Finally, amiloride did not inhibit uPA:PAI-1 endocytosis (Fig. 7E).
These experiments demonstrate that uPAR is constitutively
internalized by an amiloride-sensitive, macropinocytic mechanism.
The small GTPases RhoA, Rac-1 and Cdc42 are not
involved in the constitutive endocytosis of uPAR
Rho family GTPases participate in different clathrin-indepen-
dent endocytic pathways, including macropinocytosis [24–25].
Moreover, Rac1 is required for uPAR-induced changes in cell
morphology and motility [20]. Therefore, we investigated whether
RhoA, Rac1 and Cdc42 were involved in the regulation of the
constitutive uPAR internalization. For this purpose we tested by
confocal microscopy the ability of anti-uPAR antibodies to be
internalized in HEK293-uPAR cells transiently transfected with
GFP-tagged dominant negative mutants of RhoA (DN RhoA-
GFP), Rac1 (DN-Rac1-GFP) and Cdc42 (DN-Cdc42-GFP).
Overexpression of these GDP-bound inactive mutants did not
inhibit constitutive uPAR endocytosis (Fig 8A). To validate these
results, we repeated this experiment using a different approach.
Surface biotinylated, mutant GTPases-transfected HEK293-
uPAR cells were incubated at 37uC for 15 min. After GSH
treatment, the cells were lysed, immunoprecipitated with poly-
clonal anti-uPAR antibodies and blotted against mouse monoclo-
nal anti-uPAR antibody or directly with HRP-streptavidin. Again,
the presence of the dominant negative forms of RhoA, Rac1 or
Cdc42 had no major effect on constitutive uPAR endocytosis
(Fig. 8B). Finally, we confirmed these results by flow cytometry
evaluating the internalization of fluorescent anti-uPAR antibodies
in HEK293-uPAR cells transfected with the GFP-tagged domi-
nant negative mutants of RhoA, Cdc42 and Rac1. As shown in
Figure 5. Role of Lipid Rafts in uPA:PAI-1 dependent and
ligand-independent uPAR endocytosis. Panel A: Flotation assay
of TX-100 extracts of HEK293-uPAR analyzed by immunoblotting. uPAR
is located in both detergent-resistant (fraction 2 and 3) but mostly in
detergent-soluble fractions of the gradient (lanes 6–8). Caveolin-1
displays a similar distribution, while TfR, LRP-1, b1 integrin and EEA1 are
exclusively found in the detergent-soluble fractions. P: pellet. Panel B:
uPAR flotation in control and beta-methyl-cyclodextrin (10 mM,
30 minutes at 37uC) treated cells. Under these conditions, uPAR is
found only in detergent-soluble fractions (Lanes 6–8). Notice that the
flotation in untreated cells is the same as in Panel A. Panel C: flotation
analysis of uPAR internalization with cell surface biotinylated HEK293-
uPAR cells. UPAR is located in lipid rafts but it is internalized outside of
these microdomains. Upper row: cells treated with biotin but not
subjected to reduction with GSH, showing the distribution of uPAR
present at the cell surface. Second row: uPAR internalized in the
absence of ligands (15 min 37uC). Third row: uPA:PAI-1-dependent
uPAR internalization. Fourth row: uPAR constitutively internalized in
beta-methyl-cyclodextrin treated cells. All images are representative of
3–4 independent experiments.
doi:10.1371/journal.pone.0003730.g005
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GFP-tagged dominant negative constructs, were equally able to
internalize fluorescent anti-uPAR antibody, confirming that Rac1,
RhoA and Cdc42 activities are not required for constitutive uPAR
endocytosis. In summary, these results suggest that uPAR
endocytosis employs an amiloride-sensitive and small GTPase-
independent internalization mechanism, possibly a related form of
macropinocytosis.
PI3K activity is not required for uPAR constitutive
endocytosis
PI3K regulates macropinocytosis by inducing actin ruffles [26].
uPAR internalization assays by cell biotinylation were performed
in HEK293-uPAR cells treated with the PI3K inhibitor Wort-
mannin (300 nM, 1 hour) in order to test the requirement of this
kinase in uPAR constitutive macropinocytic uptake. Interestingly,
we observed that inhibition of PI3K with Wortmannin slightly
Figure 6. Ultrastructural visualization of uPAR endocytic vesicles. HEK293-uPAR cells were incubated with anti-uPAR monoclonal antibody
R3 (that recognizes the D1 extracellular domain) at 4uC for 20 minutes, washed and then probed with protein A gold 10 nm in the absence and in the
presence of 200 nM RAP. After extensive washing, cells were warmed in culture medium for 5 to 20 minutes at 37uC to reveal the identity of uPAR
primary endocytic vesicles. Samples were then fixed in 2.5% Glutaraldehyde in 0.1 M Sodium Cacodylate buffer and processed for standard EM plastic
embedding. At t=0, uPAR labelling was observed along the plasma membrane, especially in membrane ruffles (R) but excluded from clathrin coated
pits (CP). Upon warming at 37uC, uPAR labelling was observed in ruffling regions of the membrane (R), and in clearly large uncoated vesicular profiles
of similar morphology to macropinosomes (MP) at t=5 and t=20 minutes as well as in early endocytic elements at 20 minutes. uPAR is visible in
endocytic vescicles upon 20 minutes internalization in the presence of 200 nM RAP. Note the full macropinosome (MP) and the empty clathrin-
coated pit (CP).
doi:10.1371/journal.pone.0003730.g006
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more evident in the presence of both RAP and Wortmannin
(Fig. 9A–B). These results indicate that the constitutive uptake of
uPAR does not require PI3K activity. Taking these results
together, we defined the uPAR constitutive internalization as a
mechanism that shares the amiloride-sensitivity of macropinocy-
tosis but does not require described factors for macropinocytic
processes. We presume that the observed stimulation of uPAR
endocytosis when PI3K and small GTPases function were
perturbed is due to a general induction of alternative/compensa-
tory pathways in order to maintain cell viability under stressing
conditions. This concept agrees with recent views that cells might
sort specific cargo in alternative pathways, under different
conditions [27].
Discussion
Endocytosis controls the cellular response to ligands by targeting
the ligands for degradation in the lysosome. On the other hand,
recycling of the receptors allows the re-stimulation of a signalling
pathway. It has been established that LRP-1 mediates the
clearance of uPA:PAI-1 complexes from the extracellular milieu
and that this process is accompanied by concomitant internaliza-
tion of uPAR ro which it is bound via uPA [8–9]. Internalization
of uPAR after binding of the uPA:PAI-1 complex allows to
attenuate the extracellular proteolysis (by degradation of the ligand
and its inhibitor) and to reposition the receptor at the cell surface
after recycling [8–11]. Despite the fact that uPA:PAI-1 mediated
endocytosis via clathrin-coated pits is largely accepted to be
responsible for the removal of uPAR from the plasma membrane,
a clathrin-independent and RAP insensitive internalization route
for uPA:PAI-1 occupied uPAR has been reported in non-polarized
MDCK cells, indicating that uPAR might be internalized also by
other mechanisms [28]. Constitutive ligand-independent uPAR
endocytosis does not appear to be due to overexpression as it is
observed in naturally expressing, non transfected, HT1080 cells
(Figure 1), in Hela cells and in different HEK293-uPAR clones
expressing lower level of uPAR (not shown).
In this paper we have described a new pathway responsible for
the constitutive endocytosis of uPAR in HEK293-uPAR in the
absence of uPA and PAI-1. This unusual pathway was associated
with rapid recycling of the receptor to the cell surface and did not
Figure 7. Amiloride inhibits uPAR constitutive uptake in a dose-dependent manner. Panel A. Biotinylation experiments in HEK293-uPAR
cells incubated in the absence or presence of amiloride. Lane 1: background, Lane 2: constitutively internalized uPAR, Lane 3: inhibition by amiloride.
Panel B: Amiloride inhibits dose-dependently constitutive uPAR endocytosis measured by the cell cytometry assay. Panel C: 5 mM Amiloride
specifically inhibits uPAR and 70kDa-Dextran endocytosis, but not Transferrin receptor endocytosis, as observed by the cell cytometry assay. Panel D:
Amiloride specifically inhibits uPAR and CD59 but not LRP-1 endocytosis, as observed by the cell cytometry assay. Panel E: Amiloride inhibits uPAR
but not uPA:PAI-1 dependent endocytosis, measured by the cell cytometry assay.
doi:10.1371/journal.pone.0003730.g007
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regulatory proteins such as members of the Rho GTPases and PI3K,
usually involved in macropinocytosis and in promoting cell motility.
Biochemical and immunofluorescence studies provided clear evi-
dence that constitutive uPAR endocytosis did not require LRP-1
association since it is insensitive to RAP and does not employ
commonly used endocytic routes that are dependent on clathrin, as
demonstrated by the use of hypertonic medium and the eps15
dominant negative mutant (Fig. 4). Many clathrin-independent
routes require clustering of receptors, including GPI-anchored
receptors, in specific cholesterol-rich sub-domains of the plasma
membrane termed lipid rafts [10] and cholesterol perturbation
significantly affects their endocytosis [17]. However, rare clathrin-
independent and lipid rafts-independent routes have also been
reported [29]. Despite the fact that specific lipid environment is
instrumental for some functions of uPAR [4–5], flotation analyses
combined with internalization assays clearlyshowed that endocytosed
uPAR did not partition in low density fractions of sucrose gradients,
and lipid-rafts disruption by methyl-b-cyclodextrin did not affect
either uPA-PA1-dependent or the constitutive uPAR endocytosis.
Macropinocytosis is a form of bulk uptake of fluid and cargo into
cytoplasmic vacuoles, called macropinosomes. Thisprocess requires
extensive plasma membrane reorganization, actin remodelling as
well as the coordinated activity of several regulatory proteins.
Macropinocytosis is constitutive in some cell types (e.g. dendritic
cells and macrophages) but it is also prominent in cells stimulated
with growth factors (such as EGF) [30–34]. The dynamics of this
pathway is still poorly understood, however recent studies support
the concept of regulated bidirectional trafficking of macropino-
somes, possibly a compensatory mechanism to replete the surface
area lost during the endocytic process [35]. Macropinocytosis has
been reported to account for the constitutive and LPS-stimulated
intracellular sorting of the GPI-anchored CD14 in promonocytic
THP-1 cells [18]. Another study reported a direct role for GPI-
anchored proteins-enriched macropinosomes in Brucella infection
of macrophages. Removal of GPI-anchored proteins from macro-
phages dramatically inhibited macropinocytosis and infection,
suggesting a direct role of GPI-anchored proteins in modulating
macropinosome function [19].
The only known mechanism that we could partially tie with the
constitutive uPAR endocytosis is macropinocytosis. Our best
evidence that uPAR is constitutively endocytosed via macropino-
cytosis comes from the ultrastructural analysis (Fig. 6). Endocy-
tosed uPAR was found in large structures originated from the
Figure 8. uPA:PAI-1-independent uPAR uptake does not require small GTPases activity. Panel A: constitutive uPAR uptake assessed by
immunofluorescence of HEK293-uPAR cells transiently transfected with DNAs encoding GFP tagged mutants of RhoA, Rac1 and Cdc42. A monoclonal
anti-uPAR antibody (R3) was bound to the cell surface, cells incubated for 30 minutes at 37uC. Cells were washed, fixed and processed for
immunofluorescence. Images (a–b) show uPAR internalization in the presence of dominant negative RhoA, (c–d) the same in the presence of
dominant negative Rac1-GFP. The bottom panel (e–f) represents uPAR internalization with dominant negative Cdc42-GFP. None of the mutants
inhibited the constitutive endocytic route responsible for uPAR uptake. Data are representative of 2–4 different experiments. Scale bars 10 mm. Panel
B: biotinylation assay of ligand-independent uPAR uptake in HEK293-uPAR cells transiently transfected with GFP-tagged dominant-negative mutants
of RhoA, Rac-1 and Cdc42. After biotinylation, cells were incubated at 37uC for 15 minutes, lysed, immunoprecipitated with anti-rabbit uPAR
antibodies and blotted with mouse monoclonal uPAR antibody or with HRP streptavidin. Western Blot analysis indicates that none of the small
GTPase mutants used had a major inhibitory effect on uPAR constitutive uptake. Panel C shows the quantification of uPAR endocytosis by flow
cytometry in cells transfected with GFP or small-GTPases-GFP constructs as indicated. Cells were incubated with a polyclonal anti uPAR antibody
bound to PE-Neutravidin at 4uC, incubated at 37uC for 15 minutes and then analysed for internalized receptor in GFP expressing cells gating upon
GFP-positive cells. These results indicate that small GTPases do not play a role in constitutive uPAR endocytosis.
doi:10.1371/journal.pone.0003730.g008
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somes. Additional evidence in this direction is that uPAR
endocytosis is sensitive to amiloride, an extremely potent inhibitor
of macropinocytosis [22]. In spite of its effectiveness, the use of
amiloride to define uptake of cargo via macropinocytosis [23–29]
has been recently criticized since amiloride also inhibits albumin
uptake in kidney epithelial cells [38–39] and alters the cellular pH
in cultured cells [40].
Constitutive internalization of uPAR, CD59 and the uptake of a
70kDa-dextran, but not of transferrin and LRP-1 was dramatically
perturbed by amiloride treatment, thus falling in the fluid-phase,
macropinocytosis category. We have also demonstrated that uPAR is
eventually sorted to EEA1-positive endosomes. Upon endocytosis,
early uPAR-enriched macropinosomes might acquire regulatory
proteins such as EEA1 and fuse with pre-existing early/sorting
endosomes. Interestingly, both the constitutive and ligand-dependent
pathways provide trafficking via EEA1-positive early endosomal
compartments and efficient recycling [8], but the latter mechanism
requires clathrin and LRP-1. Since the uPA:PAI-1-mediated route
regulates important extracellular uPAR functions, we speculate that
also the constitutive pathway supports similar functions under
different conditions, i.e. in the absence of ligands/inhibitors.
The interaction of uPAR with vitronectin induces strong cell
adhesion [2]. uPAR binds the matrix protein vitronectin as a dimer
[4] in the basal membrane of the cell. This dimerization is
dissociated by uPA:PAI-1, leaving only monomers at the basal
membrane[4]. Possibly the constitutive internalization regulatesthe
constitutive adhesion/release of uPAR/Vn adhesion which is an
important step during cell migration. Obviously, this mechanism
might operate in both ligand-dependent and independent condi-
tions, i.e. in parallel with a Clathrin/LRP-1-mediated or in a
macropinocytosis-type turnover of uPAR/vitronectin adhesion.
Therefore, EM morphology and amiloride sensitivity suggest
that constitutive uPAR endocytosis would follow a macropinocytic
route. However, classical macropinocytosis has been shown to be
lipid rafts dependent and to require Rac-1 activity and upstream
effectors such as PI3K, Ras and PLC. From our investigations,
neither Rac-1 nor PI3K appear to be required for uPAR
internalization. In fact, even though lamellipodia formation in
uPAR overexpressing cells is documented to require Rac-1 activity
[20], we found that the constitutive internalization of uPAR was
Rac-1 independent. Macropinocytic mechanisms that do not
require Rac-1 and actin dependent membrane ruffling have been
reported [22–36], suggesting that ruffling and macropinocytosis
are not entirely dependent on Rac1 activity. In addition, since all
these factors are also considerably involved in promoting cell
motility, it is possible that the uPAR constitutive pathway is not
related to cell motility. Potentially, the insensitivity to Rac-1
inhibition might also be explained as the result of a association
between uPAR and the EGF receptor [37]. In fact, uPAR
association with the EGF receptor activates ERK signalling
pathway independently of Rac-1.
The link between growth factors stimulation and macropino-
cytosis is well documented [30–33]. Growth factors stimulation has
been recently associated to a second type of ruffles termed circular
dorsal ruffles (CDR or dorsal waves). Whereas lamellipodia are
associated with cell motility, growth factor-induced circular ruffles
are involved in macropinocytosis and in three-dimensional
migration [33–34]. Whether uPAR expression induces dorsal
ruffles is currently unknown and would be of significant interest to
further elucidate the basis of the macropinocytic mechanism.
PI3K inhibitors such as the fungal metabolite Wortmannin
dramatically affect fluid phase uptake and early endosome
homotypic fusion. In macrophages, wortmannin also inhibits
macropinocytosis reducing the closure of ruffles rather than the
formation of protrusions. Our results, however, indicate that PI3K
activitywasnotrequiredfortheconstitutivesortingofuPAR(Fig.9).
Many receptors, like those necessary for maintaining cellular
homeostasis, are recycled back to the cell surface, whereas receptors
whose signals need to be attenuated are delivered to the lysosomal
compartment. We have monitored the endocytic compartments in
which uPAR travels after endocytosis. Immunofluorescence studies
using early endocytic and lysosomal markers revealed that uPAR is
distributed among the overall endocytic pathway in cells (HT1080)
producingthe naturalligands ofuPAR,howeverinHEK293-uPAR
cells uPAR failed to reach lysosomes in the absence of these ligands
(Fig. 1A, Panel B). The association of uPAR, in the absence of
ligands, with early endosomal compartments, supports its rapid
recycling, possibly to ensure efficient membrane retrieval and its
constant exposure at the leading-edge. We have demonstrated
biochemically and through flowcytometry that once uPAR is sorted
into macropinosome vesicles it is rapidly recycled back to the cell
surface (Figure 3, E–F).
In conclusion, we have described a novel mechanism supporting
constitutive endocytosis and recycling of uPAR that shares
ultrastructural properties and amiloride sensitivity with macro-
pinocytosis, while is clearly distinct from the clathrin-mediated
uPA:PAI-1 endocytic pathway. In this respect, uPAR might
represent a model for the constitutive internalization of GPI-
anchored receptors.
Materials and Methods
Cell Culture
HT1080 cells and HEK293 cells stably transfected with human
uPAR were cultured in Dulbecco’s Modified Eagle Medium
Figure 9. uPAR constitutive endocytosis does not require PI3K
activity. Panel A: Biotinylation experiments in HEK293-uPAR cells
incubated in the absence or presence of Wortmannin and RAP. Lane 1:
no treatment, Lane 2: 200 nM RAP, Lane 3: 300 nM Wortmannin, Lane 4:
Wortmannin and RAP. Wortmannin and RAP do not inhibit constitutive
uPAR endocytosis after 15 min at 37uC. Panel B: densitometric analysis
of the immunoblots of Panel A.
doi:10.1371/journal.pone.0003730.g009
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ml), glutamine and 10% fetal bovine serum at 37uCi n5 %C O 2.
HEK293-uPAR cells were maintained in 0,2 mg/ml G418.
Techniques have been described [2].
Materials
Cell culture media and supplements were purchase from Gibco-
BRL (Carlsbad, CA, USA) and plastic ware was from Costar
(Cambridge, MA, USA). Triton X-100, methyl-b-cyclodextrin,
amiloride hydrochloride hydrate, Sucrose, Wortmannin and
general laboratory chemicals were from Sigma-Aldrich (St. Louis,
MO, USA). Protein G-Sepharose beads and reduced glutathione
(GSH)werefromAmershamPharmaciaBiotech(Buckinghamshire,
UK). Secondary HRP-conjugated antibodies were from Amersham
Pharmacia Biotech (Buckinghamshire, UK). PVDF membranes
were from Millipore (MA, USA). HRP-conjugated streptavidin and
the transfection reagent Fugene 6 were from Roche (Basel,
Switzerland). Chemoluminescent substrate and EZ-linked Sulfo-
NHS-SS-Biotin werefromPierce (IL,USA).Clinicalgrade uPA was
obtained from Crinos (Italy). The polyclonal anti-uPAR antibodies
as well cy3-conjugated uPA and uPA-PAI1 were prepared as
described below. The LRP-1 agonist RAP (Receptor Associated
Protein) and the monoclonal antibodies anti-515 KDa chain (8G1)
werea generous gift from D. K. Strickland (Surgery and Physiology,
University of Maryland Medical School, Rockville). The R2, R3
and R4 anti-uPAR antibodies were kindly provided by Dr Gunilla
Høyer-Hansen (Finsen Laboratory, Copenhagen, Denmark). The
monoclonal antibody X22 (ab2731) recognising clathrin-heavy
chain was purchased from Abcam (Cambridge, UK). The
monoclonal antibodies to caveolin-1 and Transferrin Receptor
were purchased from Zymed Laboratories (San Francisco, CA,
USA). The rabbit polyclonal antibodies to Caveolin-1 were
obtained from Santa Cruz Biotechnology Inc. (Santa Cruz, CA,
USA). Monoclonal antibody to EEA-1 was a gift from C.Valetti
(MicroScoBio/IFOM Genova). The monoclonal anti LAMP-1
antibodies (H4A3) were obtained from Hybridoma Bank (Iowa
City, IA, USA). The monoclonal antibodies to CD59 were
purchased from Serotec (Oxford, UK). The donkey anti-rabbit
and donkey anti-mouse secondary antibodies labeled with fluor-
esceine and rhodamine were purchased from Jackson (Westgrove,
PA, USA). Anti-rabbit and anti-mouse Alexa 488 and Alexa 546 for
confocal experiments, as well as Phycoerythrin-Neutravidin, cy3-
labeled Transferrin and Oregon Green 70000 MW-Dextran were
purchased from Molecular Probes (Paisley, UK). BSAconjugated to
5-nm gold particles and protein A gold conjugates were purchased
fromJ.W.Slot(UtrechtMedicalSchool,Utrecht,TheNetherlands).
The wt and dominant negative, GFP-tagged versions of Eps15
(pEGFP eps15 wt and pEGFP eps15DAP2, respectively) were a
generous gift from Simona Polo, (IFOM, Milano, Italy). Dominant
negative, GFP tagged versions of the small GTPases Cdc42
(pcGFP.cdc42N17), RhoA (pcGFP.RhoAV14), Rac1
(pcGFP.RacN17) were a kind gift of Daniela Talarico (San Raffaele
Scientific Institute, Milano, Italy).
uPA:PAI-1 complexes
In order to study LRP-1-mediated uPAR internalization,
uPA:PAI-1 complexes were prepared. First, uPA and PAI-1
activity was tested. Caseinolytic zymography was done in order to
test uPA activity, by preparing agarose plates with 1% agarose,
2,5% non fat dry milk, 0,1 M Tris and 40 mg/mL plasminogen.
After solidification, holes were made in the plate in order to load
uPA. After 2 h at 37uC, clear plaques were seen in those holes
where uPA activated plasminogen. To test PAI-1 activity, reverse
caseinolytic zymography was employed. Agarose plates were
prepared with 0,8% agarose, 0,8% non-fat dry milk, 0,1 M Tris,
13 mg/mL plasminogen and 90 mg/mL uPA. After incubation 3h
at 37uC, white plaques were seen only where PAI-1 inhibited uPA
activity. Then, uPA:PAI-1 complexes were formed as previously
described [43], by combining uPA and a 5-fold molar excess of
PAI-1 overnight at 37uC , and its formation was checked by 10%
SDS-PAGE. Free uPA retaining enzymatic activity was removed
by affinity chromatography in Benzamidine Sepharose 6B. The
complexes were conjugated with cy3 dye according to the
manufacturers (Molecular Probes, Paisley, UK).
Immunofluorescence analysis and transfection
HT1080 cells and HEK293-uPAR cells were first quickly
washed in PBS and fixed in 3% paraformaldeyde in PBS at room
temperature, quenched with 30 mM NH4Cl, permeabilized with
0,1% Saponin and incubated for 20 minutes in PBS/Saponin
0,1% with a mix containing anti uPAR polyclonal antibodies or
the monoclonal antibodies (R4 or R3) and the antibodies to EEA-
1, LAMP-1, LRP-1, and clathrin markers. Fluorescent signal was
detected by the use of Alexa-conjugated 488 or 546 secondary
antibodies. For internalization of uPA-PAI1-cy3 and Transferrin-
cy3 (5 mg/ml) and the monoclonal antibody R3 (anti human
uPAR), cells grown overnight on glass coverslips, where first
washed in HBSS medium and incubated with the uPA-PAI1-cy3
complex or Transferrin-cy3 in the same medium for 10 minutes at
0uC. Cells were incubated at 37uC for 10 or 15 minutes to allow
internalization. The excess of reagents was removed by extensive
washing with HBSS and then cells were processed as previously
described. For experiments with RhoA, Rac1 and cdc42 GDP-
bound mutants, HEK293-uPAR cells were cultured on glass
coverslips and transiently transfected using Fugene 6 (Roche) for
24 hours with 1 mg of the indicated DNA construct. To analyze
uPAR trafficking under these conditions, transfected cells were
incubated with anti-uPAR mAb R3 for 30 minutes on ice, washed
twice and incubated at 37uC for 15 minutes. Cells were then fixed,
permeabilized and labelled with anti-mouse cy3 conjugated
antibody. To perturb clathrin-mediated internalization we used
Hypertonic Treament (0.45 M Sucrose, 45 minutes at 37uC) [13]
and the GFP-tagged eps15 mutant EpsD95/295 in HEK293-
uPAR cells. Cells were transfected as mentioned above. To
analyze uPAR trafficking under clathrin inhibition, we incubated
cells with anti-uPAR mAb R3 for 30 minutes on ice, washed twice
and incubated at 37uC for 15 minutes. Transferrin-cy3 was used
as a control to test the efficacy of the mutant. Cells were then fixed,
permeabilized and labelled with anti-mouse cy3 conjugated
antibody to reveal uPAR and analyzed. Confocal images were
acquired using a Leica TCS SP2 confocal microscope (Leica
Microsystems, Heidelberg, Germany). Image analyses were
performed using Adobe Photoshop version CS. For each
condition, at least 10–20 cells were imaged.
Protein distribution in sucrose density gradients
Subconfluent HEK 293-uPAR cells were washed twice with
cold PBS, collected by scraping and centrifuged 5 min at 12006g.
Cells were lysed for 30 min on ice in ice-cold buffer A (150 mM
NaCl, 2 mM EDTA, 50 mM Tris-HCl, pH 7.5) containing 1%
TX-100 and a cocktail of proteinase inhibitors (Complete, Roche,
Basel, Switzerland). Cell lysates were centrifuged at 4uC for 5 min.
at 12006g. One ml of this postnuclear supernatant was brought to
40% sucrose using 80% sucrose in buffer A plus detergent, placed
at the bottom of a ultracentrifuge tube (Beckman Instruments Inc,
Fullerton, CA, USA) and overlaid with 4 ml of 30% sucrose and
2 ml of 5% sucrose in buffer A plus detergent, and filled up with
4 ml of buffer alone. Samples were centrifuged at 0uC for 17 h at
Constitutive uPAR Endocytosis
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centrifugation, 1 ml fractions were collected from the top to the
bottom of the gradient using a pipette. Eight fractions were
collected. Fractions 2 and 3 were determined to correspond to
detergent-resistance membrane (DRM) and fractions 7 and 8 to
detergent soluble membranes (DS). Then the samples were
analyzed by SDS-PAGE followed by immunoblotting for the
proteins of interest.
Methyl-b-cyclodextrin (mCD) treatment
For biochemical analyses, HT1080 and HEK293-uPAR
transfected cells were incubated with 10 mM of mCD for
30 min at 37uC. After the treatment, sucrose density gradients
were performed as previously described [14].
Distribution of uPAR in sucrose density gradients after
endocytosis
Subconfluent cells were carefully washed in cold Ca
2+/Mg
2+-
PBS, and lysed for 30 min on ice in ice-cold buffer A (150 mM
NaCl, 2 mM EDTA, 50 mM Tris-HCl, pH 7.5) containing 1%
Triton X-100. Cell lysates were centrifuged at 4uC for 5 min at
12006g and sucrose density gradients were performed as
described before. uPAR was immunoprecipitated from the
different fractions in order to analyze the amount of receptor
internalized. For immunoprecipitation, lysates were pre-incubated
at 4uC for 2 h with protein A-sepharose beads, and then the
supernatants were incubated overnight with rabbit anti-uPAR
antibodies that had been previously bound to protein A-sepharose
beads. Beads were then washed twice in lysis buffer, and eluted in
non-reducing sample buffer. Samples were analyzed by 10% SDS-
PAGE and transferred onto PVDF. The membrane was blocked
in 5% BSA overnight and incubated with HRP-streptavidin (to
identify the internalized fraction of uPAR).
Biotinylation assay of uPAR endocytosis
Subconfluent cells were washed with Ca
2+/Mg
2+-PBS, and
acid-treated in 50 mM Glycine hydrochloride/100 mM NaCl,
pH 3, for 3 minutes at 0uC (to remove endogenously bound
ligands), and quickly neutralized with a half volume of 0.5 M
Hepes/100 mM NaCl, pH 7.4. Then, cells were incubated 1 h on
ice in the presence of 0.5 mg/mL NHS-SS-biotin in PBS. Acid
treatment efficiently eliminates any ligand bound to uPAR as
demonstrated in [11]. Biotinylated cells were then washed with
PBS and incubated at 37uC to allow internalization. The samples
were then put back on ice, washed and treated with two successive
reductions of 20 min on ice with a reducing solution containing
42 mM GSH, 75 mM NaCl, 1 mM EDTA, 1% BSA and 75 mM
NaOH. In this way, only the internalized proteins remained
biotinylated. Cells were then carefully washed in cold PBS, and
lysed with RIPA buffer (50 mM Tris pH 7,6, 150 mM NaCl, 1%
deoxycolate, 0.1% SDS, 1% Triton X-100) for 30 min. on ice.
uPAR was immunoprecipitated from lysates to analyze the
amount of receptor internalized. Peroxidase reaction was devel-
oped using ECL. A sample that was labelled but not reduced was
included as a positive control, and a sample that was labelled and
reduced, prior to incubation at 37uC, was included as a negative
control. In order to normalize the internalized fraction of uPAR
with respect to total uPAR, the membranes were stripped with
stripping buffer, blocked on 5% non-fat milk, and then incubated
with the monoclonal anti uPAR antibody R2. Band intensity was
quantified by densitometry. To study endocytosis in cells treated
with drugs, HEK293-uPAR cells were pre-incubated in medium
containing the drugs at 37uC, followed by biotinylation at 0uC and
internalization at 37uC. We used the following drugs: Wortmannin
300 nM for 1 hour, Amiloride 5 mM for 30 minutes. The
inhibitors were also added during the internalization process. In
other experiments, uPA:PAI-1 complexes were used. In this case,
cells were biotinylated and then incubated 1h at 4uC with
uPA:PAI-1 50 nM. Then, cells were washed and transferred to
37uC to allow internalization. In order to inhibit uPA:PAI-1-
dependent endocytosis, 200 nM RAP was used. For experiments
with RhoA, Rac-1 and cdc42 GDP-bound mutants, HEK293-
uPAR cells were cultured on glass coverslips and transiently
transfected with Fugene 6 (Roche) for 24 hours with 1 mg of the
indicated DNA construct, and analyzed as described above.
Recycling (biotinylation assay)
To follow uPAR recycling to the cell surface, HEK293-uPAR
cells were biotinylated as mentioned above and incubated at 37uC
for 20 minutes to allow internalization. Then cells were treated
with GSH. The amount of uPAR that was internalized in this first
step was considered as 100% of the internalized receptor for
quantification purposes. Then cells were incubated again (in
duplicates) at 37uC for 10 or 20 minutes to allow the recycling of
the biotinylated (internalized) receptor to the cell surface. Next,
one set of samples was treated with GSH, to obtain the amount of
uPAR that recycled back to the cell surface. The other set of
samples was kept with PBS instead of GSH, to obtain the amount
of receptor that was either degraded or shed from the cell surface.
Samples were collected and subjected to cell lysis, immunopre-
cipitation and immunoblotting as explained above. Recycling and
degradation were calculated by subtracting the densitometric
values of the residual biotinylated receptor, following incubation at
37uC and treatment with either GSH (recycling) or PBS
(degradation) from the total pool of internalized receptor for
20 minutes at 37uC.
Constitutive endocytosis (cell cytometry assay)
HEK293-uPAR cells were grown in 24-well plates up to 80%
confluence and were first incubated at 0uC with a biotinylated
polyclonal anti-uPAR antibody, to label the cell surface receptor.
Then cells were incubated at 0uC with Neutravidin-Phycoerythrin
(to label biotinylated antibodies). As control for autofluorescence,
cells were only incubated with Neutravidin-Phycoerythrin. One set
of samples was kept at 0uC while another set was transferred for
30 minutes at 37uC to allow internalization. Half of the samples
kept at either 0 or 37uC were acid washed at 0uC to remove the
surface-bound antibodies (AW). In this way, only the uPAR-bound
internalized antibodies remain labeled. The other half of the
samples were kept at 0uC, corresponding to total amount of
labeled receptor at the cell surface. Then cells were analyzed by
cell cytometry using a FACSCalibur cytometer (Beckton and
Dickinson). Median fluorescence (MF) values were obtained that
correspond to the amount of labeled receptor present in each set of
samples. The amount of internalized receptor was calculated by
subtracting the internalized fraction (IF) at 4uC from the
internalized fraction at 37uC. The IF at 4 and 37uC were
calculated according to:
IF~
MF AW~MF AWautofluorescence ðÞ
MF-MFautofluorescence ðÞ
  100
Other molecules tested with this assay were LRP-1, CD59,
Transferrin, 70kDa-Dextran, and uPA:PAI-1 complexes. When
amiloride was used, cells were pre-incubated with amiloride for
Constitutive uPAR Endocytosis
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internalization at 37uC in the presence of amiloride. For
experiments with RhoA, Rac1 and cdc42 GDP-bound mutants,
HEK293-uPAR cells were cultured on glass coverslips and
transiently transfected with Fugene 6 (Roche) for 24 hours with
1 mg of the indicated DNA construct, and analyzed as described
above but gating only GFP positive cells.
Electron microscopy
Uptake of 5 nm gold BSA. After washing cells with serum-
free DMEM, HT1080 cells were incubated for 2 hours at 37uC
with BSA gold (OD520 nm=5) and processed as described below.
Cryosectioning and immunolabeling. According to the
conventional protocol of Tokuyasu [41] adapted by Geuze and
Slot [42], HT1080 cells were fixed with 2% paraformaldeyde and
0.2% glutaraldeyde in PBS for 2 hours at room temperature,
embedded in 12% gelatin and cooled at 4uC for 10 minutes.
Convenient blocks were cut and infiltrated in 2.3M Sucrose
overnight and then frozen in liquid nitrogen. Ultrathin
cryosections (60 nm) were cut and picked up in 1:1 2.3M
Sucrose and 2% Metylcellulose. Cryosections were immediately
immunolabeled for uPAR with anti-uPAR antibodies and detected
with Protein A gold 10 nm as previously described [42].
Endocytic assay. For embedding in epoxy resin (Epon
LX112) the cells were grown to 80% confluence, and cultured
in normal medium or with 200 nM RAP for 1 hour at 37uC, when
indicated. Subsequently, cells were washed twice with ice cold
HBSS medium and incubated with the primary antibody
(monoclonal R3 antibody, anti-human uPAR) alone or with
200 nM RAP for 1 hour at 0uC. Cells were washed with pre-
chilled HBSS medium to remove the excess of the antibody and
incubated with a rabbit anti-mouse (Jackson, dilution 1:100) for
30 minutes at 0uC. After extensive washing, cells were incubated
with Protein A gold 10 nm (Utrecht, The Netherlands, dilution
1:80) for 30 minutes at 0uC. Cells were re-washed and incubated
with pre-warmed HBSS for different time (0 minutes, 5 minutes
and 20 minutes) at 37uC in order to allow internalization. The
RAP inhibitor was also used during endocytosis. The cells were
then processed for conventional electron microscopy. Briefly, after
fixation in 2,5% glutaraldeyde in 0.1 M Sodium Cacodylate buffer
for 10 minutes at room temperature, cells were gently scraped
from petri dishes and washed 5 minutes with 0.1 M Sodium
Cacodylate buffer. Upon centrifugation, pellets were post-fixed in
1% Osmium Tetroxide diluted in 0.1 M Sodium Cacodylate
buffer for 10 minutes at room temperature and washed with
distilled water. Then, staining for 1 hour at room temperature
with 1% Uranyl Acetate was performed. Subsequently, the pellets
were dehydrated through a graded ethanol series and embedded
in LX112 resin overnight at 42uC and 2 days at 60uC. Ultrathin
plastic sections of 50 nm were stained with Uranyl Acetate and
Lead Citrate and viewed using either a Philips CM10 or a Tecnai
G2 (FEI Company) electron microscope.
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